Pennant Group, Inc.
PNTG Nasdaq Services-Health Services Financials FY2017βFY2025
What Pennant Group, Inc. does
No business description yet.
- Legal name
- Pennant Group, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001766400-26-000014
0001766400
Revenue and margins
Pennant Group, Inc. had $948M of revenue in fiscal 2025, up 36.3% on the year before.
Net income and earnings per share
From fiscal 2017 to 2025, diluted EPS grew 11.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $36.3M in fiscal 2025, 3.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Pennant Group, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 10.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Pennant Group, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $5.2M | $2.1M | $6.1M | $24.2M | $17.0M |
| Debt incl. finance leases | $51.4M | $62.9M | $63.9M | $0.0M | $176M |
| Net debt / EBITDA | 4.9x | 3.4x | 1.9x | β0.5x | 2.6x |
| Debt / equity | 0.4x | 0.5x | 0.4x | 0.0x | 0.5x |
| Interest coverage | 2.4x | 3.3x | 4.2x | 5.5x | 7.8x |
| Current ratio | 1.1x | 1.1x | 1.1x | 1.2x | 1.1x |
| Quick ratio | 1.1x | 1.1x | 1.1x | 1.2x | 1.1x |
| Total assets | $530M | $512M | $540M | $680M | $968M |
| Total liabilities | $416M | $386M | $394M | $368M | $594M |
| Shareholders' equity | $114M | $126M | $146M | $312M | $374M |
| Net debt (β = net cash) | $46.2M | $60.8M | $57.9M | β$24.2M | $158M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 3 / 8 | 6 / 8 | 3 / 8 | 6 / 8 | 7 / 8 | 7 / 8 | 3 / 8 |
| Accruals ratio | β | β7.7% | β2.6% | β7.2% | 4.0% | β0.5% | β3.7% | β2.7% | β2.3% |
| Altman Z'' | β | 3.17 | 0.07 | 0.21 | 0.49 | 0.69 | 1.01 | 1.75 | 1.45 |
9 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | $251M | $286M | $339M | $391M | $440M | $473M | $545M | $695M | $948M |
| Operating income | $15.4M | $20.6M | $5.7M | $18.9M | $4.7M | $12.7M | $25.2M | $38.1M | $51.9M |
| Interest expense | β | $0.0M | $0.4M | $1.2M | $1.9M | $3.8M | $5.9M | $7.0M | $6.7M |
| Pretax income | $15.4M | $20.6M | $5.3M | $17.9M | $2.7M | $8.9M | $19.6M | $31.4M | $45.6M |
| Income tax | $5.4M | $4.4M | $2.1M | $2.4M | $0.6M | $1.6M | $5.7M | $7.0M | $11.9M |
| Net income | $9.9M | $15.7M | $2.5M | $15.7M | $2.7M | $6.6M | $13.4M | $22.6M | $29.6M |
| Diluted EPS | $0.36 | $0.58 | $0.11 | $0.52 | $0.09 | $0.22 | $0.44 | $0.70 | $0.84 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.04B |
| Cash flow | |||||||||
| Cash from operations | $17.3M | $23.3M | $9.6M | $50.2M | β$18.2M | $9.0M | $33.1M | $39.3M | $48.3M |
| Capital expenditure | $3.1M | $3.6M | $6.7M | $7.3M | $6.3M | $14.2M | $8.1M | $9.0M | $12.0M |
| Free cash flow | $14.1M | $19.7M | $2.8M | $43.0M | β$24.5M | β$5.1M | $25.0M | $30.3M | $36.3M |
| Depreciation and amortization | $2.5M | $3.0M | $3.8M | $4.7M | $4.8M | $4.9M | $5.1M | $6.1M | $8.5M |
| Stock-based compensation | $2.3M | $2.4M | $3.4M | $8.3M | $10.0M | $3.1M | $5.4M | $7.8M | $8.9M |
| Share buybacks | β | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M | β | β | β |
| Dividends paid | $0.0M | $0.0M | $11.6M | $0.0M | $0.0M | β | β | β | β |
| Dividends and buybacks | $0.0M | $0.0M | $11.6M | $0.1M | $0.0M | $0.0M | β | β | β |
| Balance sheet | |||||||||
| Cash and short-term investments | $0.0M | $0.0M | $0.4M | $0.0M | $5.2M | $2.1M | $6.1M | $24.2M | $17.0M |
| Total debt | β | $0.0M | $18.5M | $8.3M | $51.4M | $62.9M | $63.9M | $0.0M | $169M |
| Finance lease liabilities | β | β | β | β | β | β | β | β | $6.7M |
| Current assets | β | $29.1M | $38.7M | $59.6M | $75.8M | $73.8M | $80.1M | $123M | $167M |
| Current liabilities | β | $29.5M | $51.2M | $89.0M | $71.6M | $70.2M | $71.5M | $102M | $147M |
| Property and equipment, net | β | $10.5M | $14.6M | $17.9M | $16.8M | $26.6M | $28.6M | $43.3M | $61.0M |
| Goodwill | $28.0M | $30.9M | $41.2M | $66.4M | $74.3M | $79.5M | $91.0M | $129M | $237M |
| Intangible assets | β | $0.1M | $0.0M | β | β | β | β | β | β |
| Total assets | β | $98.2M | $448M | $507M | $530M | $512M | $540M | $680M | $968M |
| Total liabilities | β | $32.9M | $377M | $406M | $416M | $386M | $394M | $368M | $594M |
| Shareholders' equity | $59.9M | $55.9M | $71.1M | $101M | $114M | $126M | $146M | $312M | $374M |
| Margins | |||||||||
| Operating margin | 6.1% | 7.2% | 1.7% | 4.8% | 1.1% | 2.7% | 4.6% | 5.5% | 5.5% |
| EBITDA margin | 7.2% | 8.2% | 2.8% | 6.0% | 2.2% | 3.7% | 5.6% | 6.4% | 6.4% |
| Net margin | 3.9% | 5.5% | 0.8% | 4.0% | 0.6% | 1.4% | 2.5% | 3.2% | 3.1% |
| FCF margin | 5.6% | 6.9% | 0.8% | 11.0% | β5.6% | β1.1% | 4.6% | 4.4% | 3.8% |
| Returns | |||||||||
| Return on capital | β | 29.2% | 4.1% | 15.0% | 2.3% | 5.6% | 8.8% | 10.3% | 7.3% |
| Return on capital employed | β | 30.1% | 1.4% | 4.5% | 1.0% | 2.9% | 5.4% | 6.6% | 6.3% |
| Return on equity | 16.5% | 27.1% | 4.0% | 18.3% | 2.5% | 5.5% | 9.9% | 9.9% | 8.6% |
| Return on assets | β | 16.0% | 0.9% | 3.3% | 0.5% | 1.3% | 2.5% | 3.7% | 3.6% |
| Return on tangible equity | 30.9% | 63.0% | 8.5% | 45.3% | 6.7% | 14.4% | 24.5% | 12.3% | 21.6% |
| Growth | |||||||||
| Revenue growth | β | 14.0% | 18.3% | 15.5% | 12.5% | 7.6% | 15.1% | 27.6% | 36.3% |
| Net income growth | β | 59.0% | β83.8% | 518.4% | β82.9% | 146.4% | 101.4% | 68.6% | 31.1% |
| EPS growth | β | 61.1% | β81.0% | 372.7% | β82.7% | 144.4% | 100.0% | 59.1% | 20.0% |
| FCF growth | β | 39.3% | β85.6% | 1,412.4% | β157.1% | β | β | 21.3% | 19.6% |
| Share count change | β | 0.0% | 6.3% | 2.2% | 1.4% | β1.6% | 0.1% | 6.0% | 10.4% |
| Financial health | |||||||||
| Net debt / EBITDA | β | β0.0x | 1.9x | 0.3x | 4.9x | 3.4x | 1.9x | β0.5x | 2.6x |
| Debt / equity | β | 0.0x | 0.3x | 0.1x | 0.4x | 0.5x | 0.4x | 0.0x | 0.5x |
| Interest coverage | β | β | 13.8x | 15.3x | 2.4x | 3.3x | 4.2x | 5.5x | 7.8x |
| Current ratio | β | 1.0x | 0.8x | 0.7x | 1.1x | 1.1x | 1.1x | 1.2x | 1.1x |
| Quick ratio | β | 1.0x | 0.8x | 0.7x | 1.1x | 1.1x | 1.1x | 1.2x | 1.1x |
| Capital allocation | |||||||||
| Capex / revenue | 1.2% | 1.3% | 2.0% | 1.9% | 1.4% | 3.0% | 1.5% | 1.3% | 1.3% |
| Stock comp / revenue | 0.9% | 0.8% | 1.0% | 2.1% | 2.3% | 0.7% | 1.0% | 1.1% | 0.9% |
| Payouts / FCF | 0.0% | 0.0% | 408.5% | 0.2% | β | β | β | β | β |
| Quality scores | |||||||||
| Piotroski F-score | β | β | 3.0 | 6.0 | 3.0 | 6.0 | 7.0 | 7.0 | 3.0 |
| Altman Z'' | β | 3.2 | 0.1 | 0.2 | 0.5 | 0.7 | 1.0 | 1.7 | 1.5 |
| Accruals ratio | β | β7.7% | β2.6% | β7.2% | 4.0% | β0.5% | β3.7% | β2.7% | β2.3% |
Source: SEC EDGAR XBRL filings (CIK 0001766400). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.